Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer

European Cytokine Network

Volumn 19, Issue 2, 2008, Pages 92-98

  Mahmoodi, Majid ^a,b   Mir, Mohammad Reza ^a   Daryaei, Parviz ^a   Harirchi, Iraj ^a   Rezaei, Nima ^c   Mohagheghi, Mohammad Ali ^a   Mousavi Jarrahi, Alireza ^a   Nahavandian, Bijan ^a   Kavianpour, Morteza ^a   Jafari, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokine; Esophagectomy; Interferon gamma; Interleukin 2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; MITOGENIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREOPERATIVE CARE; SURGICAL APPROACH; TH1 CELL; TH2 CELL; BIOLOGICAL MODEL; CASE CONTROL STUDY; ESOPHAGUS TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; TH1 CELLS; TH2 CELLS;

EID: 55749083069     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0126     Document Type: Article

References (35)

1. Ferguson MK, Martin TR, Reeder LB, et al. Mortality after esoph agectomy: risk factor analysis. World J Surg 1997; 21: 599-603.
2. MullerJM, Erasmi H, Stelzner M, et al. Surgical therapy of oe sophageal carcinoma. Br J Surg 1990; 77: 845-57.
3. Orringer MD. Transhiatal oesophagectomy. In: Jamieson GG, De bas HT, eds. Surgery of the upper gastrointestinal tract. London: Chapman & Hall, 1994: 136-211.
4. Rudiger J, Siewert MD, Hubert J, et al. Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer). World J Surg 2003; 27: 1058-61.
5. Chu KM, Law SY, Fok M, et al. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997; 174: 320-4.
6. Bartels H, Thorban S, Siewert JR. Anterior versus posterior recon struction after transhiatal oesophagectomy: a randomized controlled trial. Br J Surg 1993; 80: 1141-4.
7. Goan YG, Chang HC, Hsu HK, et al. An audit of surgical out comes of esophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2007; 31: 536-44.
8. Connors RC, Reuben BC, NeumayerLA, et al. Comparing out comes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 2007; 205: 735-40.
9. Markewitz A, Faist E, Lang S, et al. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. EurJCar diothorac Surg 1996; 10: 61-7.
10. MarkewitzA, LanteW, FrankeA, et al. Alterations of cell mediated immunity following cardiac operations: clinical implications and open questions. Shock 2001; 16: 10-5.
11. PowrieF, Coffman RL. Cytokine regulation of T-cell function:potential for therapeutic intervention. Immunol Today 1993; 14:270-4.
12. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
13. Hung K, Hayashi R, Lafond-Walker A, et al. The central role of CD+ T cells in the antitumor immune response. J Exp Med 1998;188: 2357-68.
14. McAdam A, Pulaski B, Harkins S, et al. Coexpression of IL-2 and gamma-IFN enhances tumor immunity. Ann N Y Acad Sci 1993; 690: 349-51.
15. Faist E, Storck M, Hultner L, et al. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery1992; 112: 562-72.
16. Abraham E. Chang Y-H. The effects of hemorrhage on mitogeninduced lymphocyte proliferation. Circ Shock 1985; 15: 141-9.
17. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun1997; 65: 2283-91.
18. Berguer R, Bravo N, Bowyer M, et al. Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release ofhelperT-cell type 2 cytokines. ArchSurg 1999; 134: 540-4.
19. Owens WD, Felts JA, Spitznagel Jr. EL. ASA physical status classification: a study of consistency of ratings. Anesthesiology 1978; 49: 239-43.
20. Miles EA, Bakewell L, Calder PC. Production of lymphocyte derived cytokines by whole umbilical cord blood cultures stimulated with mitogens and allergens. Cytokine 2003; 21: 74-83.
21. van Sandick JW, Boermeester MA, Gisbertz SS, et al. Lympho cyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome. Cancer Immunol Immunother 2003; 52: 617-24.
22. van Sandick JW, Gisbertz SS, ten Berge IJ, et al. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg 2003; 237: 35-43.
23. Tsutsui S, Sonoda K, Sumiyoshi K, et al. Prognostic significance of immunological parameters in patients with esophageal cancer. Hepatogastroenterology 1996; 43: 501-9.
24. Bentdal OH, Fr0land SS, Bosnes V, et al. Alterations in lympho cyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus. Cancer Lett 1996; 100: 133-8.
25. Ogawa K, Hirai M, Katsube T, et al. Suppression of cellular immunity by surgical stress. Surgery 2000; 127: 329-36.
26. Koenig A, Koenig UD, Heicappel R, Stoeckel H. Differences in lymphocyte mitogenic stimulation pattern depending on anaesthesia and operative trauma: I. Halothane-nitrous oxide anaesthesia. Eur J Anaesthesiol 1987; 4: 17-24.
27. Faist E, Ertel W, Mewes A, etal. Trauma-induced alterations of lymphokine cascade. In: Faist E, Ninnemann JL, Green D, eds. The Immune Consequences of Trauma, Shock and Sepsis. Berlin: Springer-Verlag, 1989: 79-94.
28. Brand JM, Frohn C, Luhm J, et al. Early alterations in the number of circulating lymphocyte subpopulations and enhanced proin flammatory immune response during opioid-based general anes thesia. Shock 2003; 20: 213-7.
29. Kotani N, Hashimoto H, Sessler DI, et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propo fol and isoflurane anesthesia. Anesth Analg 1999; 89: 1250-6.
30. Tashiro T, Yamamori H, Takagi K, et al. Changes in immune function following surgery for esophageal carcinoma. Nutrition 1999; 15: 760-6.
31. Tabata T, Hazama S, Yoshino S, Oka M. Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers. Am J Surg 1999; 177: 203-8.
32. Heriot AG, Marriott JB, Cookson S, et al. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer 2000; 82: 1009-12.
33. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended tran sthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. NEnglJMed2002; 347: 1662-9.
34. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagec tomy for treatment of benign and malignant esophageal disease. World J Surg 2001; 25: 196-203.
35. Rentz J, Bull D, Harpole D, et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J ThoracCardiovasc Surg 2003; 125: 1114-20.